Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Uterine Tubes01:16

Uterine Tubes

2.1K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.1K
Endotracheal Tube Extubation01:24

Endotracheal Tube Extubation

3.8K
Endotracheal tube extubation is a critical procedure in weaning patients from mechanical ventilation. It involves physically removing the oral or nasal endotracheal (ET) tube, marking the final step in liberating a patient from ventilatory support.
Procedure
Extubation removes the endotracheal tube (ETT) from the patient on mechanical ventilation. It requires a well-coordinated, multidisciplinary approach involving physicians, nurses, respiratory therapists, and other healthcare professionals....
3.8K
Tracheostomy: Procedure and Tubes01:28

Tracheostomy: Procedure and Tubes

3.0K
A tracheostomy is a surgical procedure that creates an artificial opening into the trachea, typically at the second or third cartilaginous ring level. This opening allows the insertion of a tracheostomy tube, which can replace an endotracheal tube, provide mechanical ventilation, bypass an upper airway obstruction, or remove accumulated tracheobronchial secretions.
Tracheostomy tubes can be made of semiflexible plastic (polyurethane or silicone), rigid plastic, or metal, and they come in...
3.0K
Rise of Liquid in a Capillary Tube01:18

Rise of Liquid in a Capillary Tube

3.2K
When very thin cylindrical tubes, called capillaries, are dipped in a liquid, the liquid rises or falls in the tube compared to the surrounding liquid. This phenomenon is called capillary action. Capillary action occurs due to the combination of two opposing forces: the cohesive forces of the liquid, which cause it to stick to itself and form a rounded shape, and the adhesive forces between the liquid and the walls of the container, which cause the liquid to be attracted to the container walls.
3.2K
Steady, Laminar Flow in Circular Tubes01:23

Steady, Laminar Flow in Circular Tubes

1.1K
Hagen-Poiseuille flow describes a viscous fluid's steady, incompressible flow through a cylindrical tube with a constant radius R. This flow profile is often applied to understand fluid transport in narrow channels, such as capillaries. It serves as a foundational example of laminar flow. In this model, cylindrical coordinates (r,θ,z) are used to describe the radial (r), angular (θ), and axial (z) dimensions within the tube. For Hagen-Poiseuille flow, the velocity profile is purely axial,...
1.1K
Cleavage and Blastulation01:33

Cleavage and Blastulation

50.0K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
50.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

HPV Vaccination at the Time of Abortion Visit: A Quality Improvement Initiative.

Journal of lower genital tract disease·2026
Same author

ASCO neoadjuvant chemotherapy in ovarian cancer guideline: A SGO endorsement.

Gynecologic oncology·2025
Same author

Evaluating the National Academy of Science Engineering and Medicine's recommended sexual orientation and gender identity questions: community perceptions.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2025
Same author

Erratum: Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Systemic Cancer Therapy: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Related Experiment Video

Updated: Jan 22, 2026

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells
11:46

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells

Published on: May 9, 2011

20.1K

Fallopian Tube Carcinoma.

Marina Stasenko1, Olga Fillipova1, William P Tew1

  • 11 Memorial Sloan Kettering Cancer Center, New York, NY.

Journal of Oncology Practice
|July 9, 2019
PubMed
Summary

Primary fallopian tube carcinoma, a rare cancer often grouped with ovarian cancers, is challenging to treat. Novel therapies like PARP inhibitors show promise, especially for BRCA-mutated patients, improving survival rates.

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Genetics

Background:

  • Primary fallopian tube carcinoma is a rare gynecologic malignancy.
  • Often classified under epithelial ovarian cancer, recent evidence suggests a fallopian tube origin for some ovarian cancers.
  • Treatment traditionally involves surgery and platinum-based chemotherapy, with ongoing debates regarding optimal timing and delivery methods.

Purpose of the Study:

  • To review the pathologic etiology of primary fallopian tube carcinoma.
  • To describe hereditary factors, treatment challenges, and controversies.
  • To summarize emerging novel therapeutic strategies.

Main Methods:

  • Literature review of primary fallopian tube carcinoma.
  • Analysis of current treatment modalities including surgery and chemotherapy.

More Related Videos

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.9K
An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell Analyses
07:03

An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell Analyses

Published on: March 28, 2025

1.2K

Related Experiment Videos

Last Updated: Jan 22, 2026

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells
11:46

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells

Published on: May 9, 2011

20.1K
Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
08:09

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection

Published on: July 25, 2017

12.9K
An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell Analyses
07:03

An Efficient Method for Extracting Human Fallopian Tube Epithelia for Single-cell Analyses

Published on: March 28, 2025

1.2K
  • Evaluation of novel targeted therapies such as bevacizumab and PARP inhibitors.

    • Main Results:

    • Primary fallopian tube carcinoma presents diagnostic and therapeutic challenges.
    • Debates persist regarding optimal surgical timing and chemotherapy administration (intravenous, intraperitoneal, dose-dense).
    • Poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitors demonstrate significant efficacy in BRCA1/2-mutated patients, prolonging survival.

    Conclusions:

    • Primary fallopian tube carcinoma requires specialized management strategies.
    • Novel targeted therapies, particularly PARP inhibitors, represent a significant advancement, especially in BRCA-mutated populations.
    • Further research is needed to refine treatment protocols and integrate new therapies effectively.